MERS vaccine candidate enters Phase 2 trial
by Press Release from Outbreak News Today on (#5N0AQ)
NewsDesk @bactiman63 Pennsylvania-based Inovio announced today that the company has dosed the first Phase 2 trial subject in its quest to develop the first vaccine against the Middle East Respiratory Syndrome (MERS). INOVIO's Phase 2 trial is designed to evaluate INO-4700, its DNA vaccine candidate for the prevention of MERS, a disease in the coronavirus family [...]
The post MERS vaccine candidate enters Phase 2 trial appeared first on Outbreak News Today.